Information  X 
Enter a valid email address

MaxCyteIncStk $0.01DI (MXCT)

Date Time Source Announcement
08 May 2019 4:41 pm
RNS
Second Price Monitoring Extn
  4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  4:36 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Phase I Clinical Trial of MCY-M11 Progressed
  7:00 am
RNS
Phase I Clinical Trial of MCY-M11 Progressed
01 May 2019 7:00 am
RNS
ASGCT Presentation on First CARMA Drug Candidate
24 Apr 2019 7:00 am
RNS
Final Results for Year Ended 31 December 2018
  7:00 am
RNS
Final Results for Year Ended 31 December 2018
08 Apr 2019 7:00 am
RNS
Launch of ExPERTT Instrument Family
  7:00 am
RNS
Launch of ExPERTT Instrument Family
26 Mar 2019 7:00 am
RNS
Notice of Full Year Results
  7:00 am
RNS
Notice of Full Year Results
19 Mar 2019 5:05 pm
RNS
Director Dealings
  5:05 pm
RNS
Director Dealings
05 Mar 2019 7:00 am
RNS
Grant of Options
  7:00 am
RNS
Grant of Options
01 Mar 2019 7:00 am
RNS
Clinical & Commercial Agreement with Kite
  7:00 am
RNS
Clinical & Commercial Agreement with Kite
26 Feb 2019 5:32 pm
RNS
Result of Special Meeting and Issue of Equity
  5:32 pm
RNS
Result of Special Meeting and Issue of Equity
05 Feb 2019 4:32 pm
RNS
Results of Placing
  4:32 pm
RNS
Results of Placing
  7:00 am
RNS
Proposed Placing to raise a minimum of �10 million
  7:00 am
RNS
Proposed Placing to raise a minimum of �10 million
15 Jan 2019 7:00 am
RNS
Trading Update
  7:00 am
RNS
Trading Update
19 Dec 2018 7:00 am
RNS
Change of Auditor
  7:00 am
RNS
Change of Auditor
17 Dec 2018 6:06 pm
RNS
Director Dealings
  6:06 pm
RNS
Director Dealings
21 Nov 2018 7:00 am
RNS
Consolidation of Trading Lines
20 Nov 2018 7:00 am
RNS
Block Admission Six Monthly Return/TVR
16 Nov 2018 7:00 am
RNS
Webinar: non-viral cell engineering
14 Nov 2018 7:00 am
RNS
Clinical and Commercial License Agreement
12 Nov 2018 7:00 am
RNS
MaxCyte Announces Research Agreement with Kite
09 Nov 2018 7:00 am
RNS
Expansion of CRISPR Commercial License Agreement
31 Oct 2018 4:25 pm
RNS
Result of AGM
10 Oct 2018 7:00 am
RNS
Dosing Begins in First Clinical Trial of MCY-M11
08 Oct 2018 7:00 am
RNS
Notice of AGM
24 Sep 2018 7:00 am
RNS
Results for the Half Year ended 30 June 2018
10 Sep 2018 7:00 am
RNS
Grant of Options
03 Sep 2018 7:00 am
RNS
Notice of Half Year Results
26 Jul 2018 5:33 pm
RNS
Director/PDMR Shareholding
16 Jul 2018 7:00 am
RNS
FDA IND Clearance for First Clinical Programme
  7:00 am
RNS
Trading Update
11 Jun 2018 7:00 am
RNS
MaxCyte & NIH enter CRADA for Sickle Cell Disease
21 May 2018 7:00 am
RNS
Preclinical Results at ASGCT Annual Meeting
30 Apr 2018 7:00 am
RNS
Notice of AGM and Annual Report
25 Apr 2018 7:00 am
RNS
CMO Appointment
04 Apr 2018 7:00 am
RNS
Final Results for Year Ended 31 December 2017
15 Mar 2018 7:00 am
RNS
Notice of Full Year Results
28 Feb 2018 5:00 pm
RNS
Director/PDMR Shareholding
15 Feb 2018 7:00 am
RNS
Grant of Options
13 Feb 2018 7:00 am
RNS
Dr Richard Douglas Joins MaxCyte Board
01 Feb 2018 4:06 pm
RNS
Block listing Interim Review
23 Jan 2018 1:32 pm
RNS
Total Voting Rights
22 Jan 2018 7:00 am
RNS
Trading Update
12 Jan 2018 5:13 pm
RNS
Total Voting Rights
30 Nov 2017 3:26 pm
RNS
Total Voting Rights
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t